International Journal of Clinical Pharmacy

, Volume 33, Issue 2, pp 200–207 | Cite as

Documenting clinical pharmacist intervention before and after the introduction of a web-based tool

  • Zubeir A. Nurgat
  • Abdulrazaq S. Al-Jazairi
  • Nada Abu-Shraie
  • Ahmed Al-JedaiEmail author
Research Article


Objectives To develop a database for documenting pharmacist intervention through a web-based application. The secondary endpoint was to determine if the new, web-based application provides any benefits with regards to documentation compliance by clinical pharmacists and ease of calculating cost savings compared with our previous method of documenting pharmacist interventions. Setting A tertiary care hospital in Saudi Arabia. Method The documentation of interventions using a web-based documentation application was retrospectively compared with previous methods of documentation of clinical pharmacists’ interventions (multi-user PC software). Main outcome measure The number and types of interventions recorded by pharmacists, data mining of archived data, efficiency, cost savings, and the accuracy of the data generated. Results The number of documented clinical interventions increased from 4,926, using the multi-user PC software, to 6,840 for the web-based application. On average, we observed 653 interventions per clinical pharmacist using the web-based application, which showed an increase compared to an average of 493 interventions using the old multi-user PC software. However, using a paired Student’s t-test there was no statistical significance difference between the two means (P = 0.201). Using a χ2 test, which captured management level and the type of system used, we found a strong effect of management level (P < 2.2 × 10–16) on the number of documented interventions. We also found a moderately significant relationship between educational level and the number of interventions documented (P = 0.045). The mean ± SD time required to document an intervention using the web-based application was 66.55 ± 8.98 s. Using the web-based application, 29.06% of documented interventions resulted in cost-savings, while using the multi-user PC software only 4.75% of interventions did so. The majority of cost savings across both platforms resulted from the discontinuation of unnecessary drugs and a change in dosage regimen. Data collection using the web-based application was consistently more complete when compared to the multi-user PC software. Conclusions The web-based application is an efficient system for documenting pharmacist interventions. Its flexibility and accessibility, as well as its detailed report functionality is a useful tool that will hopefully encourage other primary and secondary care facilities to adopt similar applications.


Clinical pharmacy interventions Documentation Hospital pharmacy Saudi Arabia 



We are indebted to both past and present pharmacy staff for their contribution to the intervention study, namely Khaled Alhaidari and Ibrahim Hamasni, the pharmacy informatics and automation team, Amar Hijazi, Bashar Horanieh, and Nuhad Abuzaid for technical assistance, Abdelrahman Abukhdeir and Brenda McIntyre for critical review of the manuscript and Hanif Khalak for assistance with the statistical analysis of the data.


This research received no specific grant from any funding agency in public, commercial or not-for-profit sectors.

Conflicts of Interest

None of the authors have any conflicts of interest to declare.


  1. 1.
    Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systemic review. Arch Intern Med. 2006;166:955–64.PubMedCrossRefGoogle Scholar
  2. 2.
    Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States Hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy. 2001;21:129–41.PubMedCrossRefGoogle Scholar
  3. 3.
    Chisholm MA, Vollenweider LJ, Mulloy LL, Wynn JJ, Wade WE, DiPiro JT. Cost-benefit analysis of a clinical pharmacist-managed medication assistance program in a renal transplant clinic. Clin Transpl. 2000;14:304–7.CrossRefGoogle Scholar
  4. 4.
    Ghandi PJ, Smith BS, Tataronis GR, et al. Impact of a pharmacist on drug costs in a coronary care unit. Am J Health-Syst Pharm. 2001;58:497–503.Google Scholar
  5. 5.
    Keely JL. American college of physicians-American society of internal medicine pharmacist scope of practice. Ann Intern Med. 2002;136:79–85.PubMedGoogle Scholar
  6. 6.
    Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy. 2002;22:134–47.PubMedCrossRefGoogle Scholar
  7. 7.
    Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm. 2002;59:2089–92.PubMedGoogle Scholar
  8. 8.
    Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–8.PubMedCrossRefGoogle Scholar
  9. 9.
    American Society of Health-System Pharmacists. ASHP guidelines on documenting pharmaceutical care in patient medical records. Am J Health-Syst Pharm. 2003;60:705–7.Google Scholar
  10. 10.
    Society of Hospital Pharmacists of Australia Committee of Speciality Practice in Clinical Pharmacy, Dooley M, Bogovic A, Carroll M, Cuell S, Galbraith K, Mathews H. SHPA standards of practice for clinical pharmacy. J Pharm Pract Res. 2005;35(2):122–46.Google Scholar
  11. 11.
    Royal Pharmaceutical Society of Great Britain. Guidance on recording interventions. APRIL 2006; [cited 15/05/2009]. Available at
  12. 12.
    Zimmerman CR, Smolarek RT, Stevenson JG. A computerized system to improve documentation and reporting of pharmacists’ clinical interventions, cost savings, and workload activities. Pharmacotherapy. 1995;15:220–7.PubMedGoogle Scholar
  13. 13.
    Kanmaz TJ, Haupt BA, Peterson AM. Comparison of manual and bar-code application for documenting pharmacists’ interventions. Am J Health Syst Pharm. 1997;54:1623–6.PubMedGoogle Scholar
  14. 14.
    Langebrake C, Hilgarth H. Clinical pharmacists’ interventions in a German hospital. Pharm World Sci. 2010;32:194–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Youngmee K, Gregory S. Pharmacist intervention documentation in US health care systems. Hosp Pharm. 2003;38:1141–7.Google Scholar
  16. 16.
    Miller T, Sandilya R, Tordoff J, Ferguson R. Documenting pharmacist’s clinical interventions in New Zealand hospitals. Pharm World Sci. 2008;30:99–106.CrossRefGoogle Scholar
  17. 17.
    McLennan DN, Dooley MJ. National survey of clinical activity documentation practices. Aust J Hosp Pharm. 2000;30:6–9.Google Scholar
  18. 18.
    Al Jedai AH, Hamasni IM, Al Alhaidari KM. Documenting the value of pharmacist clinical interventions. ACCP/ESCP International congress on clinical pharmacy. Pharmacotherapy. 1999;9:507. Poster presentation.Google Scholar
  19. 19.
    Al-Jazairi AS, Al Agil AA, Asiri YA, Al-Kholi TA, Akhras NS, Honranieh BK. The impact of clinical pharmacist in a cardiac-surgery intensive care unit. Saudi Med J. 2008;29:227–81.Google Scholar
  20. 20.
    Cousins D, Gerrrett D, Luscombe D. Reliability and validity of hospital pharmacists’ clinical intervention data. Am J Health Syst Pharm. 1997;54:1596–603.PubMedGoogle Scholar
  21. 21.
    Mutnick AH, Sterba KJ, Peroutka JA, Sloan NE, Belt EA, Sorenson MK. Cost savings and avoidance from clinical interventions. Am J Health Syst Pharm. 1997;54:392–6.PubMedGoogle Scholar
  22. 22.
    Gallindo C, Olivé M, Lacasa C, Martinex J, Rourse C, Lladó M, et al. Pharmaceutical care: pharmacy involvement in prescribing in an acute-care hospital. Pharm World Sci. 2003;25:56–64.CrossRefGoogle Scholar
  23. 23.
    Hawkey CJ, Hodgson S, Norman A, Daneshmend TK, Garner ST. Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ. 1990;300:986–90.PubMedCrossRefGoogle Scholar
  24. 24.
    Fox BI, Felkey BG, Berger BA, Krueger KP, Rainer RK Jr. Use of personal digital assistants for documentation of pharmacists’ interventions: a literature review. Am J Health Syst Pharm. 2007;64(14):1516–25.PubMedCrossRefGoogle Scholar
  25. 25.
    Ford S, Illich S, Smith L, Franklin A. Implementing personal digital assistant documentation of pharmacist interventions in a military treatment facility. J Am Pharm Assoc. 2006;46:589–93.CrossRefGoogle Scholar
  26. 26.
    Lynx DH, Brockmiller HR, Connelly RT, Crawford SY. Use of a PDA-based pharmacist intervention system. Am J Health Syst Pharm. 2003;60:2341–4.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Zubeir A. Nurgat
    • 1
  • Abdulrazaq S. Al-Jazairi
    • 1
  • Nada Abu-Shraie
    • 1
  • Ahmed Al-Jedai
    • 1
    Email author
  1. 1.Division of Pharmacy Services, King Faisal Specialist Hospital and Research CentreRiyadhSaudi Arabia

Personalised recommendations